Temporal Lobe Malformations in Achondroplasia: Expanding the Brain Imaging Phenotype Associated with FGFR3-Related Skeletal Dysplasias

References

1. 1.↵
   2. Horton WA,
   3. Hall JG,
   4. Hecht JT

   . Achondroplasia. Lancet 2007;370:162–72 doi:10.1016/S0140-6736(07)61090-3 pmid:17630040

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Waller DK,
   3. Correa A,
   4. Vo TM, et al

   . The population-based prevalence of achondroplasia and thanatophoric dysplasia in selected regions of the US. Am J Med Genet A 2008;146A:2385–89 doi:10.1002/ajmg.a.32485 pmid:18698630

   CrossRefPubMed
3. 3.↵
   2. Bellus GA,
   3. Hefferon TW,
   4. Ortiz de Luna RI, et al

   . Achondroplasia is defined by recurrent G380R mutations of FGFR3. Am J Hum Genet 1995;56:368–73 pmid:7847369

   PubMedWeb of Science
4. 4.↵
   2. Naski MC,
   3. Wang Q,
   4. Xu J, et al

   . Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nat Genet 1996;13:233–37 doi:10.1038/ng0696-233 pmid:8640234

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Vajo Z,
   3. Francomano CA,
   4. Wilkin DJ

   . The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans. Endocr Rev 2000;21:23–39 pmid:10696568

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Hevner RF

   . The cerebral cortex malformation in thanatophoric dysplasia: neuropathology and pathogenesis. Acta Neuropathol 2005;110:208–21 doi:10.1007/s00401-005-1059-8 pmid:16133544

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Linnankivi T,
   3. Mäkitie O,
   4. Valanne L, et al

   . Neuroimaging and neurological findings in patients with hypochondroplasia and FGFR3 N540K mutation. Am J Med Genet A 2012;158A:3119–25 doi:10.1002/ajmg.a.35642 pmid:23165795

   CrossRefPubMed
8. 8.↵
   2. Philpott C,
   3. Widjaja E,
   4. Raybaud C, et al

   . Temporal and occipital lobe features in children with hypochondroplasia/FGFR3 gene mutation. Pediatr Radiol 2013;43:1190–95 doi:10.1007/s00247-013-2684-3 pmid:23649205

   CrossRefPubMed
9. 9.↵
   2. Pugash D,
   3. Lehman AM,
   4. Langlois S

   . Prenatal ultrasound and MRI findings of temporal and occipital lobe dysplasia in a twin with achondroplasia. Ultrasound Obstet Gynecol 2014;44:365–68 doi:10.1002/uog.13359 pmid:24616001

   CrossRefPubMed
10. 10.↵
    2. Richette P,
    3. Bardin T,
    4. Stheneur C

    . Achondroplasia: from genotype to phenotype. Joint Bone Spine 2008;75:125–30 doi:10.1016/j.jbspin.2007.06.007 pmid:17950653

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Trotter TL,
    3. Hall JG

    . Health supervision for children with achondroplasia. Pediatrics 2005;116:771–83 doi:10.1542/peds.2005-1440 pmid:16140722

    Abstract/FREE Full Text
12. 12.↵
    2. Kao SC,
    3. Waziri MH,
    4. Smith WL, et al

    . MR imaging of the craniovertebral junction, cranium, and brain in children with achondroplasia. AJR Am J Roentgenol 1989;153:565–69 doi:10.2214/ajr.153.3.565 pmid:2763957

    CrossRefPubMed
13. 13.↵
    2. Miller E,
    3. Blaser S,
    4. Shannon P, et al

    . Brain and bone abnormalities of thanatophoric dwarfism. AJR Am J Roentgenol 2009;192:48–51 doi:10.2214/AJR.08.1524 pmid:19098178

    CrossRefPubMed
14. 14.↵
    2. Fink AM,
    3. Hingston T,
    4. Sampson A, et al

    . Malformation of the fetal brain in thanatophoric dysplasia: US and MRI findings. Pediatr Radiol 2010;40(suppl 1):S134–37 doi:10.1007/s00247-010-1697-4 pmid:20499057

    CrossRefPubMed
15. 15.↵
    2. Blaas HG,
    3. Vogt C,
    4. Eik-Nes SH

    . Abnormal gyration of the temporal lobe and megalencephaly are typical features of thanatophoric dysplasia and can be visualized prenatally by ultrasound. Ultrasound Obstet Gynecol 2012;40:230–34 doi:10.1002/uog.11127 pmid:22374812

    CrossRefPubMed
16. 16.↵
    2. Peters K,
    3. Ornitz D,
    4. Werner S, et al

    . Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis. Dev Biol 1993;155:423–30 doi:10.1006/dbio.1993.1040 pmid:8432397

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Thomson RE,
    3. Kind PC,
    4. Graham NA, et al

    . FGF receptor 3 activation promotes selective growth and expansion of occipitotemporal cortex. Neural Dev 2009;4:4 doi:10.1186/1749-8104-4-1 pmid:19192266

    CrossRefPubMed
18. 18.↵
    2. Grosso S,
    3. Farnetani M,
    4. Berardi R, et al

    . Medial temporal lobe dysgenesis in Muenke syndrome and hypochondroplasia. Am J Med Genet A 2003;120A:88–91 doi:10.1002/ajmg.a.10171 pmid:12794698

    CrossRefPubMed
19. 19.↵
    2. Anderson J,
    3. Burns HD,
    4. Enriquez-Harris P, et al

    . Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand. Hum Mol Genet 1998;7:1475–83 doi:10.1093/hmg/7.9.1475 pmid:9700203

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Tokumaru AM,
    3. Barkovich AJ,
    4. Ciricillo SF, et al

    . Skull base and calvarial deformities: association with intracranial changes in craniofacial syndromes. AJNR Am J Neuroradiol 1996;17:619–30 pmid:8730180

    Abstract
21. 21.↵
    2. Raybaud C,
    3. Di Rocco C

    . Brain malformation in syndromic craniosynostoses, a primary disorder of white matter: a review. Childs Nerv Syst 2007;23:1379–88 doi:10.1007/s00381-007-0474-7 pmid:17882438

    CrossRefPubMed
22. 22.↵
    2. Stark Z,
    3. McGillivray G,
    4. Sampson A, et al

    . Apert syndrome: temporal lobe abnormalities on fetal brain imaging. Prenat Diagn 2015;35:179–82 doi:10.1002/pd.4515 pmid:25297884

    CrossRefPubMed